Disfiguring sorafenib associated eruptive squamous cell carcinomas in a patient with acute myeloid leukemia

Ann Dermatol Venereol. 2023 Mar;150(1):59-60. doi: 10.1016/j.annder.2022.08.006. Epub 2022 Nov 25.

¹ Dermatology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon. Electronic address: [email protected].
² Dermatology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
³ Hematology-Oncology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
⁴ Dermatology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon; Pathology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

No abstract available

Keywords: Eruptive squamous cell carcinoma; Keratoacanthoma; Sorafenib.

Publication types